Michael J. LaBarre, SVP, Chief Technical Officer: Halozyme Therapeutics HALO Sell · Filed 24/02/28

Trade details

Type: Insider sale
Amount: $399,500
Shares · price: 10,000 sh · $39.95 a share
Held after: 159,087 sh
Stock: Halozyme Therapeutics HALO
Person: Michael J. LaBarreSVP, Chief Technical Officer
Trade date: 24/02/27
Filed: 24/02/28
Days to filing: 1 days

Sold 5.9% of holdings

Share of holding sold: 5.9%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/28~24/03/28

Michael J. LaBarre's recent trades

Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$546K
9,400 sh
$546K
Filed 25/02/27
Traded 25/02/26
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$539.5K
9,300 sh
$539.5K
Filed 25/02/27
Traded 25/02/25
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$93K
1,597 sh
$93K
Filed 25/02/27
Traded 25/02/27
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$41.1K
700 sh
$41.1K
Filed 25/02/27
Traded 25/02/25
Michael J. LaBarreSVP, Chief Technical Officer
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$35.2K
600 sh
$35.2K
Filed 25/02/27
Traded 25/02/26

Michael J. LaBarre, Chief Officer — sold $399.5K of Halozyme Therapeutics HALO · 5.9% of holdings · 10b5-1 plan | Whalegun